Vitamin D and Cardiovascular Disease

[1]  J. Hokanson,et al.  Vitamin D Deficiency and Coronary Artery Calcification in Subjects With Type 1 Diabetes , 2011, Diabetes Care.

[2]  H. Struijker‐Boudier,et al.  The metabolic syndrome and carotid intima-media thickness in relation to the parathyroid hormone to 25-OH-D(3) ratio in a general population. , 2011, American journal of hypertension.

[3]  Daniel L. Koller,et al.  Association of the Vitamin D Metabolism Gene CYP24A1 With Coronary Artery Calcification , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[4]  A. Vaidya,et al.  Vitamin D and Hypertension: Current Evidence and Future Directions , 2010, Hypertension.

[5]  B. Horne,et al.  Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. , 2010, The American journal of cardiology.

[6]  A. Avenell,et al.  Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis , 2010, BMJ : British Medical Journal.

[7]  S. Booth,et al.  Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. , 2010, The American journal of clinical nutrition.

[8]  E. Hyppönen,et al.  25-Hydroxyvitamin D and Pre-Clinical Alterations in Inflammatory and Hemostatic Markers: A Cross Sectional Analysis in the 1958 British Birth Cohort , 2010, PloS one.

[9]  C. Langefeld,et al.  Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans. , 2010, The Journal of clinical endocrinology and metabolism.

[10]  R. Jorde,et al.  Serum 25-Hydroxyvitamin D Levels Are Strongly Related to Systolic Blood Pressure But Do Not Predict Future Hypertension , 2010, Hypertension.

[11]  Kevin Fiscella,et al.  Vitamin D, Race, and Cardiovascular Mortality: Findings From a National US Sample , 2010, The Annals of Family Medicine.

[12]  S. Bandinelli,et al.  Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults , 2009, European Journal of Clinical Nutrition.

[13]  N. Powe,et al.  25-hydroxyvitamin D levels, race, and the progression of kidney disease. , 2009, Journal of the American Society of Nephrology : JASN.

[14]  G. Nijpels,et al.  Vitamin D and mortality in older men and women , 2009, Clinical endocrinology.

[15]  Markku Heliövaara,et al.  American Journal of Epidemiology Original Contribution Vitamin D Status and the Risk of Cardiovascular Disease Death , 2022 .

[16]  J. Norris,et al.  Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. , 2009, The Journal of clinical endocrinology and metabolism.

[17]  Lawrence J Appel,et al.  Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population , 2009, Pediatrics.

[18]  Carlos A Camargo,et al.  Prospective Study of Serum 25‐Hydroxyvitamin D Level, Cardiovascular Disease Mortality, and All‐Cause Mortality in Older U.S. Adults , 2009, Journal of the American Geriatrics Society.

[19]  B. Kestenbaum,et al.  25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. , 2009, Journal of the American Society of Nephrology : JASN.

[20]  D. Ertuğrul,et al.  Increased Levels of 25 Hydroxyvitamin D and 1,25-Dihydroxyvitamin D After Rosuvastatin Treatment: A Novel Pleiotropic Effect of Statins? , 2009, Cardiovascular Drugs and Therapy.

[21]  Z. Massy,et al.  Vitamin D affects survival independently of vascular calcification in chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[22]  Carlos A Camargo,et al.  Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. , 2009, Archives of internal medicine.

[23]  C. Zoccali,et al.  Vitamin D levels and patient outcome in chronic kidney disease. , 2009, Kidney international.

[24]  E. Rampersaud,et al.  Serum 25-Hydroxyvitamin D Levels Are Not Associated with Subclinical Vascular Disease or C-Reactive Protein in the Old Order Amish , 2009, Calcified Tissue International.

[25]  J. O’Keefe,et al.  Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? , 2008, Journal of the American College of Cardiology.

[26]  D. Whellan,et al.  Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). , 2008, The American journal of cardiology.

[27]  Elizabeth A Yetley,et al.  Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. , 2008, The American journal of clinical nutrition.

[28]  D. V. von Mühlen,et al.  Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. , 2008, The American journal of clinical nutrition.

[29]  I. Reid,et al.  Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. , 2008, Archives of internal medicine.

[30]  G. Curhan,et al.  Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension Among Young Women , 2008, Hypertension.

[31]  W. März,et al.  Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. , 2008, The Journal of clinical endocrinology and metabolism.

[32]  S. Draibe,et al.  Vitamin D status of chronic kidney disease patients living in a sunny country. , 2008, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[33]  B. Charra,et al.  Vitamin D deficiency and associated factors in hemodialysis patients. , 2008, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[34]  A. Reunanen,et al.  Serum Vitamin D and Subsequent Occurrence of Type 2 Diabetes , 2008, Epidemiology.

[35]  W. März,et al.  Low Vitamin D Levels Predict Stroke in Patients Referred to Coronary Angiography , 2008, Stroke.

[36]  B. Astor,et al.  25-hydroxyvitamin D levels and the risk of mortality in the general population. , 2008, Archives of internal medicine.

[37]  G. Simonetti,et al.  High-dose calcitriol therapy and progression of cardiac vascular calcifications. , 2008, Journal of nephrology.

[38]  Stefan Pilz,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[39]  S. Mohr,et al.  The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide , 2008, Diabetologia.

[40]  E. Rimm,et al.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. , 2008, Archives of internal medicine.

[41]  J. Woo,et al.  Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. , 2008, The American journal of clinical nutrition.

[42]  P. Raggi,et al.  Serum 25-Hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001 to 2004 , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[43]  A. Akobeng,et al.  Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis , 2008, Archives of Disease in Childhood.

[44]  G. Tenderich,et al.  Poor outcome in end‐stage heart failure patients with low circulating calcitriol levels , 2008, European journal of heart failure.

[45]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[46]  P. Barber,et al.  Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial , 2008, BMJ : British Medical Journal.

[47]  R. D'Agostino,et al.  Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. , 2007, American journal of epidemiology.

[48]  J. Craig,et al.  Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease , 2007, Annals of Internal Medicine.

[49]  D. V. von Mühlen,et al.  Vitamin D, Parathyroid Hormone Levels, and the Prevalence of Metabolic Syndrome in Community-Dwelling Older Adults , 2007, Diabetes Care.

[50]  M. Wolf,et al.  Vitamin D levels and early mortality among incident hemodialysis patients. , 2007, Kidney international.

[51]  B. Hollis,et al.  Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UVB dose and skin color. , 2007, Journal of the American Academy of Dermatology.

[52]  Sara Gandini,et al.  Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[53]  B. Kestenbaum,et al.  25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[54]  Keith C. Norris,et al.  Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. , 2007, Archives of internal medicine.

[55]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[56]  Edward Giovannucci,et al.  Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension , 2007, Hypertension.

[57]  A. Dueñas,et al.  Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease. , 2007, The American journal of cardiology.

[58]  J. Manson,et al.  Calcium/Vitamin D Supplementation and Cardiovascular Events , 2007, Circulation.

[59]  R. Blumenthal,et al.  Vitamin D supplementation and cardiovascular disease risk. , 2007, Circulation.

[60]  R. Koerfer,et al.  Vitamin D and vascular calcification , 2007, Current opinion in lipidology.

[61]  B. Obermayer-Pietsch,et al.  Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease , 2002, Journal of General Internal Medicine.

[62]  L. Carbone,et al.  Micronutrients in African-Americans with decompensated and compensated heart failure. , 2006, Translational research : the journal of laboratory and clinical medicine.

[63]  E. Bedrick,et al.  Mortality risk among hemodialysis patients receiving different vitamin D analogs. , 2006, Kidney international.

[64]  G. Targher,et al.  Serum 25‐hydroxyvitamin D3 concentrations and carotid artery intima‐media thickness among type 2 diabetic patients , 2006, Clinical endocrinology.

[65]  L. Carbone,et al.  Secondary Hyperparathyroidism and Hypovitaminosis D in African-Americans with Decompensated Heart Failure , 2006, The American journal of the medical sciences.

[66]  Beatrice A. Golomb,et al.  Peripheral Arterial Disease: Morbidity and Mortality Implications , 2006, Circulation.

[67]  D. Grimes.  Are statins analogues of vitamin D? , 2006, The Lancet.

[68]  S. Yusuf,et al.  Homocysteine lowering with folic acid and B vitamins in vascular disease. , 2006, The New England journal of medicine.

[69]  Per Magne Ueland,et al.  Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.

[70]  G. Tenderich,et al.  Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.

[71]  J. Manson,et al.  Vitamin D and calcium intake in relation to type 2 diabetes in women. , 2006, Diabetes care.

[72]  E. Warburton,et al.  Reduced Vitamin D in Acute Stroke , 2006, Stroke.

[73]  J. Manson,et al.  Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. , 2005, Diabetes care.

[74]  C. Mathieu,et al.  Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[75]  M. Holick,et al.  Vitamin D intakes by children and adults in the United States differ among ethnic groups. , 2005, The Journal of nutrition.

[76]  R. Koerfer,et al.  Putting cardiovascular disease and vitamin D insufficiency into perspective , 2005, British Journal of Nutrition.

[77]  Hyung Wook Kim,et al.  Calcitriol Regresses Cardiac Hypertrophy and QT Dispersion in Secondary Hyperparathyroidism on Hemodialysis , 2005, Nephron Clinical Practice.

[78]  C. Mathieu,et al.  Vitamin D and diabetes , 2005, Diabetologia.

[79]  T. Rönnemaa,et al.  Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. , 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[80]  L. Acheson.  Bone density and the risk of fractures: should treatment thresholds vary by race? , 2005, JAMA.

[81]  E. Ford,et al.  Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. , 2005, Diabetes care.

[82]  M. Hernán,et al.  Activated injectable vitamin D and hemodialysis survival: a historical cohort study. , 2005, Journal of the American Society of Nephrology : JASN.

[83]  Ali H. Mokdad,et al.  State of Disparities in Cardiovascular Health in the United States , 2005, Circulation.

[84]  L. Kuller,et al.  The Pittsburgh insulin-dependent diabetes mellitus registry: Seasonal incidence , 1982, Diabetologia.

[85]  J. Nerup,et al.  Incidence, seasonal and geographical patterns of juvenile-onset insulin-dependent diabetes mellitus in Denmark , 1977, Diabetologia.

[86]  C. Barton,et al.  Vitamin D fortification in the United States and Canada: current status and data needs. , 2004, The American journal of clinical nutrition.

[87]  K. Özoran,et al.  The Effects of Calcitriol Therapy on Serum Interleukin-1, Interleukin-6 and Tumour Necrosis Factor-α Concentrations in Post-menopausal Patients with Osteoporosis , 2004, The Journal of international medical research.

[88]  D. Oliver,et al.  Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease , 2004, American Journal of Nephrology.

[89]  Craig S Anderson,et al.  Very Long-Term Outcome After Stroke in Auckland, New Zealand , 2004, Stroke.

[90]  G. Lamas,et al.  Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. , 2004, American heart journal.

[91]  M. Saad,et al.  Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .

[92]  L. Chambless,et al.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. , 2004, JAMA.

[93]  M. Gannagé-Yared,et al.  Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women , 2003, Journal of endocrinological investigation.

[94]  M. Wolf,et al.  Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. , 2003, The New England journal of medicine.

[95]  G. Curhan,et al.  Time trends in reported prevalence of kidney stones in the United States: 1976-1994. , 2003, Kidney international.

[96]  G. Tenderich,et al.  Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? , 2003, Journal of the American College of Cardiology.

[97]  M. Holick,et al.  Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. , 2003, The American journal of clinical nutrition.

[98]  G. Hitman,et al.  Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? , 2002, QJM : monthly journal of the Association of Physicians.

[99]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[100]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[101]  G. Mundy,et al.  Statins and bone formation. , 2001, Current pharmaceutical design.

[102]  M. Holick,et al.  Decreased bioavailability of vitamin D in obesity. , 2000, The American journal of clinical nutrition.

[103]  J. Avorn,et al.  HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. , 2000, JAMA.

[104]  H. DeLuca,et al.  Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. , 2000, Archives of biochemistry and biophysics.

[105]  T. Drüeke,et al.  Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. , 1999, Kidney international.

[106]  R. Vieth,et al.  Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. , 1999, The American journal of clinical nutrition.

[107]  C. Park,et al.  Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[108]  H. Blom,et al.  Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials , 1998, BMJ.

[109]  Y. Arad,et al.  Serum concentration of calcium, 1,25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography study , 1998, Coronary artery disease.

[110]  B. Hollis,et al.  Vitamin D Metabolism Is Altered in Asian Indians in the Southern United States: a Clinical Research Center Study* Skin Fibroblast Studies , 2022 .

[111]  K. Watson,et al.  Active serum vitamin D levels are inversely correlated with coronary calcification. , 1997, Circulation.

[112]  G E Dallal,et al.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.

[113]  R. Detrano,et al.  Ethnic origin and serum levels of 1alpha,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. , 1997, Circulation.

[114]  D. Mancini,et al.  Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. , 1997, The American journal of medicine.

[115]  R. Lindsay,et al.  Resistance to Bone Resorbing Effects of PTH in Black Women , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[116]  E. Feskens,et al.  Vitamin D, glucose tolerance and insulinaemia in elderly men , 1997, Diabetologia.

[117]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[118]  H. Rasmussen,et al.  Calcium absorption responses to calcitriol in black and white premenopausal women. , 1995, The Journal of clinical endocrinology and metabolism.

[119]  M. Frey,et al.  Progression and Regression by Verapamil of Vitamin D3-Induced Calcific Medial Degeneration in Coronary Arteries of Rats , 1995, Journal of cardiovascular pharmacology.

[120]  R. Beaglehole,et al.  Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. , 1990, International journal of epidemiology.

[121]  J. Dunn,et al.  Alteration of Vitamin D metabolism in mexican‐Americans , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[122]  J. Adams,et al.  INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3 , 1982, The Lancet.

[123]  D. Thelle,et al.  Tromsø Heart Study: vitamin D metabolism and myocardial infarction. , 1979, British medical journal.

[124]  B. Lund,et al.  Vitamin D and Ischaemic Heart Disease , 1978, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[125]  W. Loomis.  Skin-Pigment Regulation of Vitamin-D Biosynthesis in Man , 1967, Science.